Ro was launched as Roman in October 2017 by Zachariah Reitano, Saman Rahmanian, and Rob Schutz.[3] Reitano's personal experience with a heart condition, and his desire to recreate his father, a doctor, out of software, inspired him to co-found the company.[4][5][6] Ro raised $3.1 million in a seed funding round led by General Catalyst and launched with a telemedicine practice, in addition to a pharmacy, to distribute medications.[7] In September 2018, the company renamed itself Ro and expanded its treatment to additional pathologies like hair loss, cold sores, and premature ejaculation.[8][9]
In 2018, Ro raised $88 million in a Series A funding round led by FirstMark Capital, and added Reddit Founder Alexis Ohanian as a board director.[10] In 2019, Ro expanded to offer services for women.[11] In January 2020, Ro partnered with Pfizer for the sourcing of Sildenafil.[12] In July 2020, Ro raised $200 million in a series C funding round.[13] In March 2021, Ro raised $500 million in a series D funding round led by General Catalyst, FirstMark Capital, and TQ Ventures, giving the company a $5 billion valuation.[14] Margo Giorgiadis, formerly the CEO of Ancestry.com, also joined Ro’s Board of Directors.[15]
In 2021, Ro acquired Modern Fertility and Kit.[16]
Ro began to treat obesity through supplying Gelesis100.[22] In January 2023, Ro expanded obesity treatment through GLP-1 receptor agonists through its Body Program.[23][24] An ad campaign for Ro’s Body Program on the New York City Subway was criticized for being too "evocative".[25] After the medication gained FDA approval in 2023, Ro began prescribing Zepbound to medically-eligible patients through its Body Program.[26]
Platform
Ro patients fill out a dynamic online visit answering questions about their health, lifestyle, medical history, and symptoms. A physician then reviews the results and prescribes medication if appropriate. Medications are shipped directly to the patient's home.[27] Ro's platform is vertically integrated with labs and pharmacies in the United States.[28][29]
Research
In October 2022, Ro reached an agreement with the National Institute on Aging to create a registry of patients for future Alzheimer's disease research and clinical trials.[30] Ro has published research on a variety of telehealth topics, including comparable rates of side effects found with treatment via asynchronous and synchronous virtual care.[31]
Acquisitions
In December 2020, the company acquired WorkPath, which sends phlebotomists into patient homes to draw blood for diagnostic tests.[14]
On May 19, 2021, the company announced that it had acquired women's reproductive health company Modern Fertility, in a deal reported to be over $225 million.[32]
On June 30, 2021, the company announced the acquisition of Kit, a startup offering at-home diagnostic tests, including finger prick blood tests and weight measurement tools.[33]
^"ATA2021ATA2021 Annual Conference & Expo (Virtual) Tuesdays and Thursdays in June 2021". Telemedicine and e-Health. 27 (6): A–1–A-21. 2021. doi:10.1089/tmj.2021.29056.abstracts.